This content is from: Premium Jana’s Latest Target The activist hedge fund has already enjoyed several wins this year. By Stephen Taub September 26, 2022
This content is from: Premium Averill Suffers a Setback One of the most successful new funds in recent memory has now posted losses for the past three months. By Stephen Taub September 21, 2022
This content is from: Premium Glenview Suffers an August Setback The hedge fund firm headed by Larry Robbins has been scaling back its emphasis on healthcare. By Stephen Taub September 02, 2022
This content is from: Portfolio What Happens When a Company Is a Climate Hero and a Governance Disaster? Across the board, companies with high levels of impact-aligned revenue showed signs of only slightly lower ESG risk, according to a Morningstar report. By Jessica Hamlin September 07, 2022
This content is from: Premium Glenview Liquidates a Long-Held Major Holding Larry Robbins’ firm disclosed several big moves in its second-quarter 13F document. By Stephen Taub August 12, 2022
This content is from: Premium SEC Charges Perceptive Advisors The regulator has accused the life sciences firm headed by Joseph Edelman of engaging in violations related to its SPACs. By Stephen Taub September 06, 2022
